PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 44: Articles 21501-22000 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. Contraception for women with liver disease.
  2. Contraception in adolescence. [Zur Problematik der Kontrazeption bei Jugendlichen.]
  3. Contraception in diabetic women. [Contraception chez la diabetique.]
  4. Contraception in female heart patients. [La contraception de la femme cardiaque.]
  5. Contraception in Norway. [Prevensjonsbruken i Norge.]
  6. Contraception in the Arab world.
  7. Contraception in women at high vascular and metabolic risk. Clinical trail of a 17 alpha-hydroxyprogesterone derivative. [Contraception des femmes a hauts risques vasculaires et metaboliques. Essai d'un derive de la 17 alpha-hydroxyprogesterone.]
  8. Contraception today.
  9. Contraception tomorrow.
  10. Contraception with an LH-RH agonist: effect on gonadotrophin and steroid secretion patterns.
  11. Contraception with levonorgestrel-releasing subdermal capsules, Norplant, after pregnancy termination.
  12. Contraception--are women getting a fair deal.
  13. Contraception.
  14. Contraception: the health provider's guide.
  15. Contraceptive attitudes and practice in France: a report on a recent survey conducted by MFPF.
  16. Contraceptive availability and use in five developing countries.
  17. Contraceptive behavior among unmarried young women: a theoretical framework for research.
  18. Contraceptive choice in the grand multipara.
  19. Contraceptive choices for lactating and middle-aged women.
  20. Contraceptive choices may soon include convenient OTC sponge.
  21. The contraceptive consultation in Africa. [La consultation de contraception en Afrique.]
  22. Contraceptive continuation among adolescents attending family planning clinics.
  23. Contraceptive continuation rates in Papua New Guinea.
  24. Contraceptive delivery to adolescents.
  25. Contraceptive demand in Thailand: 1982-1986.
  26. Contraceptive development for the future.
  27. Contraceptive development--future perspective.
  28. Contraceptive efficacy of norethindrone acetate (ENTA) implant: its release rate and fertility potential.
  29. Contraceptive efficacy of testosterone-estradiol implants in male rhesus monkeys.
  30. Contraceptive efficacy study of 2% nonoxynol-9 gel with diaphragm.
  31. Contraceptive efficiency of female late adolescents: relationship to parents and sexual self-concept.
  32. Contraceptive failure in the United States: the impact of social economic and demographic factors (author's transl) [Echec des methodes contraceptives aux U.S.A. role des facteurs sociaux, economiques et demographiques.]
  33. Contraceptive failure rates in Latin America.
  34. Contraceptive for men.
  35. The contraceptive habits of women applying for termination of pregnancy. [Abortsogende kvinders kontraceptionsvaner.]
  36. Contraceptive implants: state of the art and prospects for the future.
  37. The contraceptive industry. Who calls the shots?
  38. Contraceptive knowledge.
  39. Contraceptive methods and epilepsy: its physiopathogenesis. [Metodos contraceptivos e epilepsia: consideracoes sobre a fisiopatogenia.]
  40. Contraceptive methods. [Les methodes de contraception.]
  41. The contraceptive pill and vascular accidents (editorial)
  42. Contraceptive practices of female runners [letter]
  43. Contraceptive practices of female runners.
  44. Contraceptive practices of teenage mothers.
  45. Contraceptive preparations of plant origin. [Kontratseptivnye preparaty rastitel'nogo proiskhozhdeniia.]
  46. The Contraceptive Prevalence Studies II: progress report No. 9, June - December 1983, Contract No. AID/DSPE-C-0052.
  47. The contraceptive prevalence survey project: content and status.
  48. Contraceptive prevalence surveys. A comparative study of contraceptive prevalence in Antigua, Dominica, St. Lucia and St. Vincent.
  49. Contraceptive risks and benefits in a developing country: the case of Egypt.
  50. Contraceptive safety research in Asia: a literature review.
  51. Contraceptive safety: the need for epidemiologic research.
  52. Contraceptive Social Marketing Information System. Description and user's guide.
  53. Contraceptive social marketing strategy workshop, May 2-5, 1983: final report.
  54. Contraceptive Social Marketing Strategy Workshop, Washington, D.C., 1-5 May 1983: program schedule.
  55. Contraceptive social marketing.
  56. Contraceptive sponge makes debut.
  57. Contraceptive sponge--diaphragm bilayer [patent]
  58. Contraceptive sponge: testimony of Susan Seidler, [National Women's Health Network], before the House Subcommittee on Intergovernmental Relations and Human Resources, Committee on Government Operations, July 13, 1983.
  59. Contraceptive use among adolescents.
  60. Contraceptive use among Asian women.
  61. Contraceptive use and efficacy in a genetically counseled population.
  62. Contraceptive use and perceptions of chance and ability of conceiving in women electing abortion.
  63. Contraceptive use by adolescent females in relation to knowledge, and to time and method of contraceptive counseling.
  64. Contraceptive use by college dating couples: a comparison of men's and women's reports.
  65. Contraceptive use by lactating women in the United States.
  66. Contraceptive use.
  67. Contraceptive-steroid potency and lipoprotein cholesterol [letter]
  68. Contraceptives and developing countries: the role of barrier methods.
  69. Contraceptives and the new trend in breast-feeding--a causal connection?
  70. Contraceptives for teenagers.
  71. Contraceptives in 1980s: proceedings of the Third Medical Symposium of Family of The Future Association, March 17-18, 1983 in Esmaielia.
  72. Contraindications for oral contraceptives. [Contraindicaciones de los contraceptivos orales.]
  73. Control of the birth rate of "marginal" populations in Brazil: an examination of a population policy. [Controle de la natalite des populations "marginales" au Bresil: examen d'une politique demographique.]
  74. Coping with contraception: cognitive and behavioral methods with adolescents.
  75. Copper release from the MLCu375 intrauterine contraceptive device.
  76. Coronary atherosclerosis and myocardial infraction in young women--role of oral contraceptives.
  77. Cost analysis of family planning service in a primary health care center in Bangladesh.
  78. Cost effectiveness of family planning services in Nepal.
  79. Counseling in voluntary surgical contraception.
  80. A counseling program of secure contraception services in Indonesia.
  81. The course of pregnancy after failure of intrauterine contraception. [Osud gravidity po zlyhani vnutromaternicovej antikoncepcie.]
  82. A cross-national comparison of contraception and abortion laws.
  83. Current functioning and future priorities in family planning services delivery.
  84. Current priorities of the Population Council's contraceptive development program.
  85. Current status of antagonistic analogs of LH-RH as a contraceptive method in the female.
  86. Current status of research and development of vaginal contraceptive rings as a fertility control method in the female.
  87. Current status of research on sperm antigens: potential applications as contraceptive vaccines.
  88. Current status of voluntary surgical contraception in the United States.
  89. Current technology for family planning: safety, effectiveness, use and delivery in low-income settings.
  90. Current trends in the development of hormonal contraception. [Sovremennye tendentsii v razvitii gormonal'noi kontratseptsii.]
  91. Cytologic atypias in the uterine fluid of intrauterine contraceptive device users.
  92. Cytologic findings in oral contraceptive users among Israeli Jewish women.
  93. Day three: information about contraception.
  94. Deaths associated with intrauterine contraceptive devices [letter]
  95. Deaths associated with intrauterine contraceptive devices [letter]
  96. Decision-making in relation to the use of contraception after delivery: a black community in Daveyton. [Besluitneming met betrekking tot die gebruik van kontrasepsie na bevalling: 'n Swart gemeenskap in Daveyton.]
  97. The demand for physician training in family planning in Piaui State, Brazil.
  98. Demographic aspects and prevalence of contraception in Peru: results of the First National Contraceptive Prevalence Survey. [Aspectos demograficos y prevalencia de anticonceptivos en el Peru: resultados de la Primera Encuesta Nacional de Prevalencia de Anticonceptivos. 1981.]
  99. Demographic characteristics, wish and intent to procreate, and the use of contraception in a group of women in Mexico City. [Caracteristicas demograficas, deseo, intencion de procreacion y uso de anticoncepcion en un grupo de mujeres de la ciudad de Mexico.]
  100. Demographic evolution of India's family planning programme.
  101. Demographic impact and economic implications of the family planning programme in Uttar Pradesh.
  102. Desire for additional children and contraceptive plans.
  103. Determinants of the use of family planning.
  104. Determining pricing policies in contraceptive social marketing.
  105. Developing counseling skills in family planning: a training guide.
  106. Developing, implementing and evaluating a socio-economic scale to study clients attending family planning clinic at the Shatby Maternity Hospital.
  107. The development of integrated health, nutrition and family planning programme in Indonesia.
  108. Differential effects of oral contraceptive steroids on the metabolism of benzodiazepines.
  109. Differential in contraceptive use and continuation in two areas of rural Bangladesh.
  110. Diffusion of family planning innovations through satisfied adopters: a strategy for programme development.
  111. Digestive effects of combined oral contraceptives: the viewpoint of the gynecologist. [Consequences digestives des oestroprogestatifs: point de vue du gynecologue.]
  112. Diocesan plan to establish a natural family planning services program. [Plan Diocesano para establecer un programa de servicios de planificacion familiar natural.]
  113. Discontinuation of contraceptives.
  114. Do copper containing intrauterine contraceptive devices need to be changed after 2 years?
  115. Does the responsibility for family planning rest primarily with the woman?
  116. Draft International Standard ISO/DIS 8009/1. Reusable rubber contraceptive diaphragms.
  117. Drug interactions with oral contraceptive steroids.
  118. Drug interactions with oral contraceptives.
  119. The dynamics of family planning acceptance in the northeast of Thailand.
  120. Dysmenorrhea in women with intrauterine contraceptive device. Treatment with a prostaglandin synthetase inhibitor, naproxen.
  121. An economic model of fertility, sex and contraception.
  122. Editorial comment [concerning surgical contraception]
  123. Education program on voluntary surgical contraception: the case of Paraguay. [Programa de educacion sobre anticoncepcion quirurgica voluntaria el caso de Paraguay.]
  124. Effects of tobacco smoking and oral contraceptive use on theophylline disposition.
  125. Effects of various combined oral contraceptives on sex steroids, gonadotropins and SHBG.
  126. Efficacy of Contrasperm as a male contraceptive: clinical trials in Malaysian men.
  127. The Egyptian Fertility Survey, 1980. Volume II: fertility and family planning.
  128. Emotional barriers to contraception.
  129. Endometrial morphological changes associated [with] the triphasic oral contraceptive.
  130. Enhancement of mutagenic activity in Salmonella by contraceptive steroids.
  131. Epilepsy and oral contraceptives: a therapeutic dilemma.
  132. Ethical issues in contraceptive technology.
  133. Ethical issues in U.S. family planning policy.
  134. Ethnic differentials in contraceptive use in Sri Lanka.
  135. The ethnic numbers game in India: Hindu-Muslim conflicts over conversion, family planning, migration, and the census.
  136. Ethynyl estradiol content of cervical mucus after administration of oral contraceptive.
  137. Ethynyloestradiol, the oestrogen in oral combination steroid contraceptive--a short review.
  138. An evaluation of a programme on sexually transmitted diseases and contraception and pregnancy.
  139. An evaluation of an adolescent family planning program.
  140. Evaluation of Columbia University's Operations Research for Family Planning Programs Cooperative Agreement.
  141. An evaluation of instructional materials on barrier methods in family planning in Kirinyaga, Kenya.
  142. An evaluation of message content in Latin American family planning literature: motivation theory vs. a feminist perspective.
  143. Evaluation of new intra-uterine contraceptive devices [letter]
  144. Evaluation of risk factors associated with vascular thrombosis in women on oral contraceptives possible role of anti-sex steroid hormone antibodies.
  145. Evaluation of steroids as contraceptives in men.
  146. Evaluation of the family planning programme, analysis of input-output relationship for studying the efficiency of the family planning programme.
  147. Evaluation of the Program of Mobilization of Community Resources for Family Planning in the State of Rio de Janeiro.
  148. Evaluation of UNFPA assistance to the family planning programme of the Dominican Republic, 1978-1982/3.
  149. Evaluation of UNFPA assistance to the family planning programme of the Dominican Republic, DOM/73/P01, 1978-1982/3. Report.
  150. Evaluation report on the Contraceptive Prevalence Studies Project.
  151. Evolution of and prospects for U.S. funding of international population and family planning programs.
  152. Executive summary: Seminar on Fertility, Family Planning and Development Issues of Population in the South of Thailand, Nora Hotel, Haad-Yai, Songkhla, 16-18 March 1983.
  153. Organisational policy for family planning.
  154. Ovarian pregnancy and the intrauterine contraceptive device.
  155. Overcoming political constraints to voluntary surgical contraception including legal issues: status of voluntary sterilization in Ecuador.
  156. An overview of family planning activities in Bangladesh.
  157. An overview of the information systems of the Indonesian National Family Planning Coordinating Board: options for systems change and development.
  158. Ovule Pharmatex: results of 10 years of research in contraception. [L'ovule pharmatex: resultat de dix ans de recherche en contraception.]
  159. Paraguay WFS: 47% of exposed women practice contraception; 30% use most effective methods.
  160. Parental notification requirements applicable to projects for family planning services. Rules and regulations.
  161. The patient's understanding of the oral contraceptive patient package insert.
  162. Perceived availability of contraceptives and family limitation.
  163. Periodic abstinence as a contraceptive method. [La abstinencia periodica como metodo anticonceptivo.]
  164. Periodic abstinence for family planning.
  165. A personal contraception record card.
  166. Personality and attitudinal barriers to contraception.
  167. The pharmacist should play an active role in family planning. [El farmaceutico debe jugar un papel activo en la planificacion familiar.]
  168. Pharmacists and family planning.
  169. Pharmacokinetics of oral contraceptive steroids after morning or evening administration.
  170. Physiological basis for contraception--2.
  171. The pill. A short history of oral contraception.
  172. The place of induced abortion in a family planning programme.
  173. Planned Parenthood and Women's Development: the needs and concerns of young women.
  174. Planned parenthood as a concern of primary health care.
  175. Planned Parenthood Association of Kansas City, Missouri, Inc., et al. v. Ashcroft, Attorney General of Missouri, et al. Certiorari to the United States Court of Appeals for the Eighth Circuit.
  176. Planning and implementation of secure contraception program in Indonesia--community based approach through institutions of higher learning.
  177. Planning the family.

     

  178. Plasma carnitine in women. Effects of the menstrual cycle and of oral contraceptives.
  179. The expediency of using natural oestrogens in combined oral contraceptive tablets. [Celszeru-e termeszetes osztrogenek alkalmazasa kombinalt oralis fogamzasgatlo tablettaban?]
  180. Experience and problems encountered with available methods in family planning programmes in India.
  181. Experience of an NGO with ongoing natural family planning programs.
  182. Experiences and observations of 80 women using the Spider Cu intrauterine contraceptive device for 2 years. [Doswiadczenia i obserwacje 80 kobiet u ktorych dla celow zapobiegania ciazy stosowano wkladke Spider Cu w okresie 2 lat.]
  183. Experiences from a sex-counseling and birth control practice for adolescents. [Erfahrungen aus ciner Sexual beratungs- und Kontrazeptiva-Sprechstunde fur Jugendliche.]
  184. Experiences of the "Nuestra Senora de la Altagracia" maternity hospital in the area of surgical contraception.
  185. Experiences of the Family Planning Association of India.
  186. An experiment about family planning attitude change.
  187. Experimental aspects of antisperm immunization of male and female organism in connection with contraception.
  188. The extent of contraceptive use and the social paradigm of modern demography.
  189. Extra-contraceptive effects and benefits of the oral contraceptive. [Efeitos e beneficios extra-contraceptivos do contraceptivo oral.]
  190. Extrauterine pregnancy and intrauterine contraception (author's transl)
  191. Factor structure of the Menstrual Symptom Questionnaire: relationship to oral contraceptives, neuroticism and life stress.
  192. Factors affecting contraceptive use among high-risk women in Korea.
  193. Factors affecting sexual and contraceptive attitudes and behaviors among adolescents.
  194. Factors affecting the use and non use of contraception.
  195. Factors associated with contraception in Bihar and Rajasthan: findings from recent sample surveys.
  196. Facts about methods of contraception.
  197. Family formation, desire for children and birth control among Swiss couples--results of a representative survey. I. Family formation and desire for children. [Familiengrundung, Kinderwunsch und Geburtenregelung bei Schweizer Ehepaaren--Ergebnisse einer reprasentativen Umfrage. I. Familiengrundung und Kinderwunsch.]
  198. Family planning activities MCH/FP clinic project headquarters - Omdurman.
  199. Family planning advertisements on radio and television.
  200. Family planning and cervical mucus. 3rd ed. [Regulation des naissances et glaire cervicale. 3e edition.]
  201. Family planning and child health in Chile: a governmental option. [Regulacion de la fecundidad y salud infantil: una opcion gubernamental.]
  202. Family planning and female sterilization in the United States.
  203. Family planning and fertility change in the developing world: alternative estimates of the independent program effect.
  204. Family planning and fertility in developed vs undeveloped squatter areas in Lahore City, Pakistan [tables]
  205. Family planning and fertility in the south of Thailand with a special emphasis on religious differentials: an analysis of data from the 1981 contraceptive prevalence survey.
  206. Family planning and fertility.
  207. Family planning and fragmented services: some lessons from history.
  208. Family planning and health work at the grassroots: some issues and new concerns in the Indian context.
  209. Family planning and health.
  210. Family planning and health: the Narangwal experiment.
  211. Family planning and maternal-child health in Mexico 1970-1980.
  212. Family planning and opposing Islamic leaders: a campaign proposal.
  213. Family planning and population control policy. [La politique de la planification familiale et du controle demographique.]
  214. Family planning and the concept of wanted births in Zaire. [Le planning familial et le concept de naissances desirables au Zaire.]
  215. Family Planning and the religious issue.
  216. Family planning as a nutrition intervention in Zaire: a rationale and case study.
  217. Family planning associations in Australia: key events from 1926 to 1983.
  218. Family planning at the grass roots.
  219. Family planning at the University College Hospital, Ibadan 1965-1982.
  220. Family planning clinics: are they a necessary supplement to primary health care? [Prevensjonskontorene: Et nodvendig supplement til primaerhelsetjenesten?]
  221. Family planning communication needs assessment and country profile for Nepal.
  222. Family planning communication needs assessment for North Sudan.
  223. Family planning communications in Guatemala: a nationwide survey.
  224. Family planning decision-making in a polygynous Nepalese family.
  225. Family planning education.
  226. Family planning in Australia.
  227. Family planning in Japanese society: traditional birth control in a modern urban culture.
  228. Family planning in perspective (editorial) [Gesinsbeplanning in perspektief.]
  229. Family planning in Spain.
  230. Family planning in Thailand: a cheerful revolution.
  231. Family planning in the Federal Republic of Germany.
  232. Family Planning in the Gambia.
  233. Family planning in the Socialist Republic of Vietnam.
  234. Family planning in Zaire. [Planification familiale au Zaire.]
  235. Family planning is a basic policy of our state.
  236. Family planning is the first and most important step for rural development.
  237. Family planning legislation. Report on a survey.
  238. Family planning methods and practice: Africa.
  239. Family planning performance at a major hospital in Sri Lanka.
  240. Family planning practices in India--Second All India Survey.
  241. The family planning program and cuts in federal spending. 1. Impact on state management of family planning funds.
  242. The family planning program and cuts in federal spending. 2. Initial effects on the provision of services.
  243. Family planning program of Pakistan. Will the change work?
  244. Family planning program on the island of Mauritius. [Programme de Planification Familiale a l'Ile Maurice.]
  245. Family planning program: Taiwan area, Republic of China, July 1981-June 1983.
  246. Family planning programme in the organized sector: case studies.
  247. The family planning programme in the People's Republic of China.
  248. Family planning programme management: Sri Lanka.
  249. Family planning programme report 1969-1983.
  250. Family planning programs: what determines their impacts? [tables]
  251. The family planning service.
  252. Family planning services from multiple provider types: an assessment for the United States.
  253. Family planning status and changes.
  254. Family planning strategies for the '80s.
  255. Family planning strategies in the 1980s.
  256. Family planning strategies in the 1980s. Current approaches to population problems, 25-29 October, 1982, Bonn-Niederbachem.
  257. Family planning training and community needs.
  258. Family planning training.
  259. Family planning update.
  260. Family planning with maternity care monitoring.
  261. The family planning work in Yiyang prefecture as suggested by part of the data of the sample fertility survey.
  262. Family planning and the liberation of Brazil. ["Planejamento familiar" a libertacao do Brasil.]
  263. Family planning, health and nutrition survey taken in Arniquet, St. Louis and Torbeck in October 1982. [Enquete sur la planification familiale, l'etat de sante et la situation nutritionelle conduite a Arniquet, St. Louis et Torbeck en Octobre 1982.]
  264. Family planning.
  265. Family planning. [Planning familial.]
  266. Family planning: a constitutional duty in China.
  267. Family size and contraceptive use among Mormons: 1965-75.
  268. The feasibility of services for postcoital contraception.
  269. Female employment, occupational setting and family planning use in a Philippine city.
  270. Fertility after stopping use of intrauterine contraceptive device.
  271. Fertility and contraception in cancer patients. [Fertilite et contraception chez les cancereux.]
  272. Fertility and family planning in Brazil.
  273. Fertility and family planning in developed countries: a summary of findings of the ECE/WFS comparative study.
  274. Fertility and family planning in Kiribati.
  275. Fertility and family planning in rural Egypt (the second Rural Fertility Survey 1982)
  276. Fertility and family planning.
  277. Fertility and family planning: some conceptual models.
  278. Fertility and prospects of family planning in The Three Towns.
  279. Fertility following hormonal contraception (author's transl) [Fertilite apres arret de la contraception hormonale.]
  280. Fertility regulation in nursing women: V. Long-term influence of a low-dose combined oral contraceptive initiated at day 90 postpartum upon lactation and infant growth.
  281. Fertility, contraceptive use, and use of oral rehydration salts in rural Beni-Suef Governorate, Egypt.
  282. Fertility, development, and family planning.
  283. Fibrinolytic activity in endometrium and uterine fluid of women using intrauterine contraceptive devices.
  284. A film program in health and family planning in rural Zaire.
  285. Final evaluation of the Caribbean Family Planning Project 538-0050.
  286. Final market introduction plan for low dose oral contraceptive, Family of the Future.
  287. Final progress report. Acceptability of a long acting injectable as a post partum contraceptive in Egypt.
  288. Final report on the development of a family planning mobile exhibit for the Egyptian State Information Service.
  289. Final report. CPAIMC Community Based Family Planning Motivation and Condom Distribution Project, Rio de Janeiro, Brazil. Draft.
  290. Final report: development and testing of vaginal contraceptives.
  291. Five-year plan for family planning communication in Nigeria.
  292. Focal nodular hyperplasia liver cell adenoma and hormonal contraceptives (author's transl) [Hyperplasie focale nodulaire, adenome hepatocellulaire et contraceptifs hormonaux.]
  293. Follow-up of adolescent family planning clinic users.
  294. Framework for coordinating population and family planning research in Egypt.
  295. Fresh impetus to family planning programmes planned in India. APPN interviews Mr. B. Shankaranand Union Minister for Health and Family Welfare, India.
  296. Further studies on sister-chromatid exchange frequency in users of hormonal contraceptives.
  297. Future prospects for human contraception. [Perspectives d'avenir en contraception humaine.]
  298. Future prospects of family planning programs.
  299. Gap in knowledge and use of contraception in Pakistan.
  300. Gastrointestinal and hepatic vascular accidents and oral contraceptives. [Accidents vasculaires hepato-digestifs et contraceptifs oraux.]
  301. The Ghana National Family Planning Programme.
  302. Global trends in contraception.
  303. A gold key to initiate a new situation in family planning work.
  304. The Greek Orthodox Church and position regarding birth control. [L'eglise chretienne orthodoxe et la question de la regulation de la fertilite.]
  305. Guidelines for the management of women on oral contraceptives with breast abnormalities.
  306. Gynecological services utilization by contraceptive clients: a cost analysis.
  307. Haitian women's attitudes toward menstruation in rural and urban settings: implications for distribution and the use of contraceptives. [Attitudes des femmes Haitiennes a l'egard de la menstruation en milieu rural et urbain: implications pour la distribution et l'utilisation de methodes contraceptives.]
  308. Handbook for family planning operations research design.
  309. The health belief model: can it help us to understand contraceptive use among adolescents?
  310. Health benefits of contraception.
  311. Health consequences of unplanned pregnancies versus contraception.
  312. The health provider's guide to contraception. International edition.
  313. Health rationale of voluntary surgical contraception.
  314. Health risks of intrauterine contraception (author's transl) [Les risques inherents a la contraception intrauterine.]
  315. The health visitor, family planning and personal relationships.
  316. Healthcare and contraception for the migrant woman: part B.
  317. Hepatic adenoma caused by contraceptives. Presentation of a case. [Adenoma hepatico por anticonceptivos. Presentacion de un caso.]
  318. Hepatic cell adenoma and pelliosis hepatis in women using oral contraceptives. [Adenoma de celulas hepaticas e peliose hepatica em mulher usando contraceptivos orais.]
  319. Hepatic clearance of aminopyrine in the evaluation of liver function in hormonal contraception. [Die hepatische Ausscheidung von Aminopyrin zur Beurteilung der Leberfunktion bei hormoneller Kontrazeption.]
  320. Hepatic disease and oral contraceptive therapy [answer to question of Weber]
  321. Hepatic hematoma and pleural hemorrhages caused by prolonged ingestion of oral contraceptives. [Hematoma hepatico y derrames pleurales por ingesta prolongada de anovulatorios orales.]
  322. Hepatocellular carcinoma and oral contraceptives.
  323. Hepatomas in young women on oral contraceptives: report of two cases and review of the literature.
  324. Hereditary uroporphyrinogen dicarboxylase deficiency in porphyria cutanea tarda cause by hormonal contraceptives (letter) [Hereditarer Uroporphyrinogen-Decarboxylase-Defekt bei Porphyria cutanea tarda durch hormonale Kontrazeptiva.]
  325. The history of research on contraceptive methods in the Dominican Republic. [Historia de la investigacion sobre metodos anticonceptivos en RD.]
  326. Homonymous hemianopsia as a rare complication of contraceptive use. [Homonyme Hemianopsie als seltene Komplikation unter Antikonzeptivaeinnahme.]
  327. Honduras: Contraceptive Prevalence Survey. Summary. [Honduras: Encuesta Nacional de Prevalencia del Uso de Anticonceptivos. Resumen.]
  328. Honduras: National Contraceptive Prevalence Survey. General findings. [Honduras: Encuesta Nacional de prevalencia del uso de Anticonceptivos. Resultados Generales.]
  329. Hormonal contraception and fibrinolysis. [Hormonale Kontrazeption und Fibrinolyse.]
  330. Hormonal contraception with Marvelon. Experience in gynecological practice--a multicenter study by 265 gynecologists in more than 26,000 women. [Hormonelle Kontrazeption mit Marvelon. Erfahrungen mit Marvelon in der gynakologischen Praxis--Multicenter-Studie bei 265 Gynakologen und uber 26,000 Frauen.]
  331. Hormonal contraception with subdermal implants (author's transl) [Contraception hormonale par des implants sous-cutanes.]
  332. Hormonal contraception--possibilities and problems. [Hormonale Kontrazeption--Moglichkeiten und Probleme.]
  333. Hormonal implants: the next wave of contraceptives.
  334. Household delivery of family planning information and condoms: Operation Research Project summary.
  335. Household distribution of contraceptives in Zaire [tables]
  336. How the family planning manager can plan communications programs for VSC to reach men in the community.
  337. How to estimate contraceptive requirements for the first time.
  338. How to evaluate a communication campaign for family planning. A demonstration based on data from the SIS program for Egypt, 1980-82.
  339. How to launch the activity of propaganda month of family planning in Sichuan province.
  340. How to select appropriate voluntary surgical contraceptive procedures for national programs.
  341. The human right to family planning.

     

  342. Human rights and voluntary surgical contraception.
  343. Humanistic family planning approaches: the integration of family planning and health goals.
  344. Ideological barriers to contraception.
  345. Ikereku mini-study: family planning issues.
  346. Immune reactivity among women on oral contraceptives.
  347. Immunoglobulins and hormonal contraception. [Imunoglobuliny a hormonalni antikoncepce.]
  348. Impact of family planning on fertility reduction in West Bengal.
  349. The impact of family planning programs on infant, child, and maternal mortality.
  350. Impact, effectiveness, and efficiency of the AFPH programs on family planning status in 20 provinces.
  351. Importance of coordination between government and non-government organisations in making the Voluntary Surgical Contraception Programme successful.
  352. Improving the cost effectiveness of community-based distribution family planning programs by reducing the frequency of routine supervision: An experimental study.
  353. Inactivation of contraceptive steroid hormones by human intestinal clostridia.
  354. Inaugural address: FPAI Seminar on "Family Planning as a People's Programme: New Approaches and Strategies," Bombay, 12th August 1983.
  355. Incentives for family planning?
  356. Incidence of arterial disease among oral contraceptive users. Royal College of General Practitioners' Oral Contraception Study.
  357. Incidence of arterial hypertension in women taking oral hormonal contraceptive agents (femigen) [Ocena wystepowania nadcisnienia tetniczego krwi u kobiet stosujacych doustne hormonalne srodki antykoncepcyjne (femigen)]
  358. Incidence of pelvic inflammatory disease in clinical trials with Cu-7 (intrauterine copper contraceptive): a statistical analysis.
  359. Increased urinary androgen levels in patients with carcinoma in situ of the breast with onset while taking oral contraceptives.
  360. Increasing the effectiveness of community workers through training of spouses: a family planning experiment in Guatemala.
  361. India's family planning programme: its impact and implications.
  362. Indicators of contraceptive policy for nations at three levels of development.
  363. Indirect estimation of infant mortality from Contraceptive Prevalence Surveys.
  364. Individual levels of plasma alpha2-antiplasmin and alpha2-macroglobulin during the normal menstrual cycle and in women on oral contraceptives low in oestrogen.
  365. Induced abortion and contraceptives--urgent problems of health care. [Iskusstvennye aborty, kontratseptsiya--aktual'nye problemy sovremennogo zdravookhraneniya.]
  366. Infant and child survival and contraceptive use in the closed pregnancy interval.
  367. Inferior vena cava thrombosis with oral contraceptives documented by computed tomography.
  368. Influence of augmented Hageman factor (Factor XII) titers on the cryoactivation of plasma prorenin in women using oral contraceptive agents.
  369. Influence of background and programme factors on the family planning programme in India.
  370. Influence of sex and oral contraceptive steroids on paracetamol metabolism.
  371. Information, education, and communication for voluntary surgical contraception.
  372. Informational barriers to contraception.
  373. Informational materials for contraceptive introduction.
  374. Informed consent for family planning: an analysis of the legal and ethical issues.
  375. Injectable and other types of steroid contraceptives.
  376. Injectable contraception using depot progestagens. [Anticoncepcion inyectable con progestagenos de deposito.]
  377. Injectable contraception.
  378. The injectable contraceptive debate: an update.
  379. Injectable contraceptives, their safety and efficacy.
  380. Institutional factors affecting teenagers' choice and reasons for delay in attending a family planning clinic.
  381. Instructions on family planning at the ambulatory clinic of Nagasaki University Hospital: the current status of training in pessary use.
  382. Instructions on the fitting and use of cervical and vault contraceptive caps.
  383. Instrument for removing intrauterine contraceptives. [Instrument dlia izvlecheniia vnutrimatochnykh kontratseptivov.]
  384. An integrated and simplified model of health services, nutrition, and family planning for rural areas. [Modelo integrado y simplificado de servicios de salud, nutricion y planificacion familiar para zonas rurales.]
  385. Integrated approach to maternal and child health and family planning.
  386. Integrated approach to MCH and family planning [letter]
  387. Integrated family planning programs: rationale, concepts and methodology for evaluation.
  388. Integrating population programmes, statement made at 10th Asian Parasite Control Organization Family Planning Conference, Tokyo, Japan, 5 September 1983.
  389. Integration of family planning programmes with health services.
  390. Intelligence, family planning, and family formation.
  391. Inter-spouse communication on the domiciliary visit of the paramedical staff and family planning acceptance.
  392. Interaction of drugs with steroidal oral contraceptives. [Interakce leku se steroidnimi oralnimi Kontraceptivy.]
  393. Interception (postcoital contraception)
  394. International Conference on the Role of the Retail Pharmacists in Family Planning, Alexandria, Egypt, April 25-28, 1983--the Alexandria Declaration.
  395. International health and family planning.
  396. International Planned Parenthood Federation and the United Nations.
  397. International standardization of mechanical contraceptives.
  398. Interrelations between maternal and neonatal health and family planning: conceptualization of the theme.
  399. Intranasal LHRH agonist (Buserelin) after ovulation: a post-coital contraceptive approach.
  400. An intrapersonal and interactional model of contraceptive behavior.
  401. Intrauterine contraception. [Antykoncepcja wewnatrzmaciczna.]
  402. Intrauterine contraception: what next and why?
  403. Intrauterine contraceptive device clinic in a group practice.
  404. Intrauterine contraceptive device insertion with suture fixation at cesarean section.
  405. Intrauterine contraceptive devices.
  406. Intrauterine contraceptive devices. Complications associated with their use.
  407. Intrauterine devices: problems encountered in family planning programmes of developing countries.
  408. Intrauterine devices: their role in family planning care.
  409. Introduction and current status of voluntary surgical contraception in the region. [Introduccion y situacion actual de la anticoncepcion quirurgica voluntaria en la region.]
  410. Introduction of contraceptives in national family planning programme: injectables and implants.
  411. An introduction to modern methods of contraception.
  412. An introduction to reproductive physiology and contraceptive methods: a programmed instruction.
  413. Inventory of selected local family planning programme experiences in countries of the ESCAP region. Volume V.
  414. Islam and family planning: a brief study.
  415. Issues in the selection and field implementation of family planning and health interventions in community-based distribution projects.
  416. Issues regarding service and psychosocial research in the provision of family planning methods.
  417. Issues requiring service and psychosocial research in the provision of family planning methods.
  418. Karnataka: pioneer in family planning.
  419. Knowledge and attitudes on sexuality among nurses in a family planning clinic in Kuala Lumpur.
  420. Knowledge, attitudes and practice of pregnant women and of women in the early postpartum period regarding family planning. [Gebe ve dogum yapmis annelerin aile planlamasina iliskin bilgi tutum ve uygulamalarinin saptanmasi.]
  421. Knowledge, attitudes and practice of the female population of La Paz city concerning conception and contraception. [Conocimientos actitudes y practicas de la poblacion femenina de la ciudad de La Paz en relacion a la concepcion y anticoncepcion.]
  422. Knowledge, attitudes and practices (KAP) study on the relation of breastfeeding and family planning in an urban and rural area of the Philippines.
  423. Knowledge, attitudes, and practices of 1,985 Buddhist monks in Thailand concerning family planning, sterilization and primary health care.
  424. Laparoscopic removal of ectopic intrauterine contraceptive devices.
  425. Late periods: attitudes concerning birth control and abortion in Switzerland from the beginning of the century to the 1920s. [Retards de regles: attitudes devant le controle des naissances et l'avortement en Suisse du debut du siecle aux annees vingt.]
  426. Latest developments in contraception.
  427. Learn Rongcheng's experience, do a good job of family planning.
  428. The legal and ethical implications of postcoital birth control.
  429. Legal barriers to voluntary surgical contraception for the mentally disabled.
  430. Legalization of permanent contraception in post-war Europe. [Legalizacion de la anticoncepcion permanente en la postguerra en Europa.]
  431. Legalizing permanent contraception in post-war Europe.
  432. Levonorgestrel releasing contraceptive devices.
  433. A life table analysis technique for the evaluation of intrauterine contraceptive devices.
  434. Liver tumors and combined oral contraceptives. [Tumeurs hepatiques et oestroprogestatifs.]
  435. Local resources: a necessity in surgical family planning programs.
  436. Locus of control and the use of contraception among unmarried black adolescent fathers and their controls: a preliminary report.
  437. Log-linear analysis of the factors affecting contraceptive use among high-risk women in Korea.
  438. Long acting contraceptives, Present status.
  439. Long-acting contraception.
  440. Long-acting contraceptive agents: analysis and purification of steroid esters.
  441. Long-acting contraceptive agents: bile acid esters of norethisterone.
  442. Long-acting contraceptive agents: carbonates and carbamates of norethisterone.
  443. Long-acting contraceptive agents: design of the WHO Chemical Synthesis Programme.
  444. Long-acting contraceptive agents: esters of norethisterone with alkoxy-and halogeno-substituted carboxylic acids.
  445. Long-acting contraceptive agents: esters of norethisterone with alpha- and/or beta-chain branching.
  446. Long-acting contraceptive agents: furylalkylcarboxylic acid esters of norethisterone.
  447. Long-acting contraceptive agents: levonorgestrel esters of unsaturated acids.
  448. Long-acting contraceptive agents: norethisterone esters of arylcarboxylic acids.
  449. Long-acting contraceptive agents: norethisterone esters of monoalkenyl and monoalkynyl acids.
  450. Long-acting contraceptive agents: structure activity relationships in a series of norethisterone and levonorgestrel esters.
  451. Lorazepam and oxazepam kinetics in women on low-dose oral contraceptives.
  452. Low-dose oral contraceptives and coagulation: comparison with high-dose oral contraceptives and intrauterine devices.
  453. Maintenance of a birth control method: the effects of attitude and distance on first-time users in Santiago, Dominican Republic.
  454. Make-up of family, desire for children and birth control in married Swiss couples: results of representative questionnaire. 2. Contraception in Switzerland: knowledge and practice among Swiss couples. [Familiengrundung, Kinderwunsch und Geburtenregelung bei Schweizer Ehepaaren--Ergebnisse einer reprasentativen Umfrage. II. Kontrazeption in der Schweiz--Kenntnisse und Praxis der Schweizer Ehepaare.]
  455. Making choices: evaluating the health risks and benefits of birth control methods.
  456. Male attitudes toward family planning in Khartoum, Sudan [tables]
  457. Male attitudes toward family planning in Khartoum, Sudan.
  458. Male contraception by nonsurgical methods. [Contraception masculine non chirurgicale.]
  459. Male contraception.
  460. Male contraceptive in stomach salve.
  461. Male contraceptive sought.
  462. The male role in contraception: Implications for health education.
  463. Malignant hypertension in women aged 15 to 44 years and its relation to cigarette smoking and oral contraceptives.
  464. Management contribution to the family planning and population programme in Uttar Pradesh, India.
  465. Management of contraceptive introduction: the case of Norplant subdermal implants.
  466. Management of maternal child health and family planning: report of the ICOMP Latin American Workshop, Lima, Peru. November 2-5, 1982.
  467. Management of maternal child health and family planning: report of the ICOMP Latin American Workshop, Lima, Peru. November 2-5, 1982.
  468. Management of the family planning programme in Indonesia.
  469. Management study of the Malaysian National Family Planning Board's programme.
  470. Managing contraceptive pill patients. 3rd ed.
  471. Managing drug interactions with oral contraceptives.
  472. Manpower and facilities for research in family planning.
  473. A manual for representatives of contraceptive social marketing programs. Contraceptive Social Marketing Detailers Manual.
  474. Manual of questions and answers on family planning. [Manual de preguntas y respuestas sobre planificacion familiar.]
  475. A marketing audit model for Contraceptive Social Marketing Programs.
  476. Mass communication, cosmopolite channels, and family planning among villagers in Mexico.
  477. Maternal child family planning survey--1981. Brazil southern region summary report, March 1982. [Pesquisa sobre saude materno-infantil e planejamento familiar--1981. Brasil regiao sul resumo, Marco 1982.]
  478. Maternal Child Health and Family Planning Survey, 1982, Amazonas, Brazil. [Pesquisa Sobresaude Materno-Infantile Planejamento Familiar, 1982. Amazonas-Brasil.]
  479. Mathematical simulation of impact of birth control policies on Indian population system.
  480. Medical and health aspects of voluntary surgical contraception.
  481. Medical and social considerations of family planning. [Consideraciones medico-sociales de la planificacion familiar.]
  482. Medical policy on contraceptive services in the Caribbean Community.
  483. Medroxyprogesterone acetate as a contraceptive for female drug addicts.
  484. Meeting the needs in surgical contraception during the 80's.
  485. Melanoma, pregnancy and oral contraception (letter) [Melanoom, zwangerschap en orale anticonceptie.]
  486. Menstrual abnormalities in the adolescent abuse of the birth control pill.
  487. Menstrual bleeding expectations and short-term contraceptive discontinuation in Mexico.
  488. Menstrual regulation versus contraception in Bangladesh: characteristics of the acceptors.
  489. Metabolic and vascular consequences of hormonal contraception in non-diabetics. [Consequences metaboliques et vasculaires de la contraception hormonale en dehors du diabete.]
  490. Methodological issues in family planning program evaluation.
  491. Methods of birth control.
  492. Mild unilateral proteinuria and renal vein thrombosis associated with oral contraceptive usage.
  493. Minimum medical standards for voluntary surgical contraception.
  494. Mode of action of dl-norgestrel and ethinylestradiol combination in postcoital contraception. II. Effect of postovulatory administration on ovarian function and endometrium.
  495. A model for market research in contraceptive social marketing.
  496. A model of marital fertility transition that incorporates diffusion of birth control.
  497. A model of premarital coitus and contraceptive behavior among female adolescents.
  498. Monetary and health costs of contraception.
  499. Monthly injectable contraceptives.
  500. Monthly injectable contraceptives.

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.